Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

J&J Must Face Lawsuits Over OTC Motrin Labeling
Pharmalot
Monday, January 23, 2012 - 2:21pm
tags:
JNJ, OTC, Motrin, lawsuits
The Best Biotech Stocks Of 2012
Seeking Alpha
Monday, January 23, 2012 - 2:19pm
tags:
Advanced Cell Technologies, Aeterna Zentaris, Antares, BioSante, Geron, Hikma, Keryx, Pfizer, Sanofi, Teva Pharmaceuticals, Transcept, Yakult Honsha, Watson Pharmaceuticals
Look to Exact Sciences, Not Radient Pharma, for Best Colon Cancer Screen Test
TheStreet.com
Monday, January 23, 2012 - 2:14pm
tags:
Radient Pharmaceuticals, colon cancer, EXACT Sciences, Onko-Sure
Earnings Preview: Abbott Labs reports 4Q results
Yahoo/AP
Monday, January 23, 2012 - 1:02pm
tags:
earnings, Abbott Laboratories
Why Amgen Is Overvalued At $70 A Share
Seeking Alpha
Monday, January 23, 2012 - 12:46pm
tags:
Amgen
Spectrum says its Zevalin drug led to higher survival rates in certain lymphoma patients
Yahoo
Monday, January 23, 2012 - 12:45pm
tags:
Zevalin, Spectrum Pharmaceuticals, lymphoma
Novo Nordisk Establishes Type 1 Diabetes R&D Center in Seattle
Yahoo
Monday, January 23, 2012 - 12:44pm
tags:
R&D, Novo Nordisk, type 1 diabetes
Tysabri label change could add $1B to sales
Fierce Pharma
Monday, January 23, 2012 - 12:00pm
tags:
Tysabri, MS, multiple sclerosis, Biogen Idec
Celgene Corp Fourth Quarter Earnings Sneak Peek
Yahoo/Wall St Cheat Sheet
Monday, January 23, 2012 - 11:56am
tags:
Celgene, earnings
CEL-SCI says Multikine Phase III trial launched in dozens of hospitals
The Fly on the Wall
Monday, January 23, 2012 - 11:25am
tags:
Cel-Sci, Multikine, head and neck cancer
FDA extends review of Alexza product, shares fall
Reuters
Monday, January 23, 2012 - 11:03am
tags:
FDA, Alexza, Adasuve, antipsychotics
Abbott: The Best Buy In This Group Of 5 Big Pharma Stocks
Seeking Alpha
Monday, January 23, 2012 - 11:02am
tags:
Abbott Laboratories, Merck, Pfizer, GSK, Bristol-Myers Squibb
Forbes Earnings Preview: Amgen
Forbes
Monday, January 23, 2012 - 11:01am
tags:
earnings, Amgen
Perrigo, Apotex Sued by Meda Over Generic Version of Astepro Nasal Spray
Bloomberg
Monday, January 23, 2012 - 11:00am
tags:
Astepro, Perrigo, Meda, Apotex, generics
2 Pharmaceutical Stocks Ready To Move
Seeking Alpha
Monday, January 23, 2012 - 9:52am
tags:
Amylin, Prolor
The Medicines Company Settles Angiomax(R) (Bivalirudin) Patent Litigations With App Pharmaceuticals
Yahoo
Monday, January 23, 2012 - 9:51am
tags:
Angiomax, patents, Medicines Company, APP
Earnings Preview: Bristol-Myers
Yahoo/Zacks
Monday, January 23, 2012 - 9:49am
tags:
earnings, Bristol-Myers Squibb
Earnings Preview For Johnson & Johnson 4Q 2011
Seeking Alpha
Monday, January 23, 2012 - 9:49am
tags:
JNJ, earnings
Pot-based prescription drug looks for FDA OK
Yahoo/AP
Monday, January 23, 2012 - 9:48am
tags:
marijuana, FDA, GW Pharma, cancer pain
Seattle Genetics: Boxed Warning Is A Non-Event
Seeking Alpha
Sunday, January 22, 2012 - 12:32pm
tags:
Seattle Genetics, progressive multifocal leukoencephalopathy, PML, Adcetris, Hodgkin's lymphoma, anaplastic large-cell lymphoma

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.